Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 25, 2009
Date of Patent
October 8, 2013
Patent Application Number
13120406
Patent Citations Received
‌
US Patent 12077590 Bispecific antibody for cancer immunotherapy
0
‌
US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
0
‌
US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11707448 Combination therapies for the treatment of cancer
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11712433 Compositions comprising PKM2 modulators and methods of treatment using the same
0
‌
US Patent 11744822 Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
‌
US Patent 11746103 ALK-5 inhibitors and uses thereof
‌
US Patent 11759454 Diazole lactams
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8552154
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.